Literature DB >> 34148364

Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis.

Jean K Ho1, Frank Moriarty2,3, Jennifer J Manly4, Eric B Larson5, Denis A Evans6, Kumar B Rajan6, Elizabeth M Hudak7, Lamiaa Hassan8, Enwu Liu9, Nobuyuki Sato10, Naoyuki Hasebe10, Danielle Laurin11, Pierre-Hugues Carmichael11, Daniel A Nation1,12.   

Abstract

[Figure: see text].

Entities:  

Keywords:  angiotensin converting enzyme inhibitors; angiotensin receptor blockers; blood-brain barrier; cognition; dementia; hypertension; renin-angiotensin system

Mesh：

Substances：

Year:  2021        PMID： 34148364      PMCID： PMC9009861          DOI： 10.1161/HYPERTENSIONAHA.121.17049

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   9.897


  82 in total

1.  Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study.

Authors:  H Petrovitch; L R White; G Izmirilian; G W Ross; R J Havlik; W Markesbery; J Nelson; D G Davis; J Hardman; D J Foley; L J Launer
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

2.  Angiotensin-(1-7) improves cognitive function in rats with chronic cerebral hypoperfusion.

Authors:  Wei Xie; Donglin Zhu; Li Ji; Minjie Tian; Chang Xu; Jingping Shi
Journal:  Brain Res       Date:  2014-05-20       Impact factor: 3.252

3.  Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study.

Authors:  Sverre E Kjeldsen; Krzysztof Narkiewicz; Michel Burnier; Suzanne Oparil
Journal:  Blood Press       Date:  2018-10       Impact factor: 2.835

4.  Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type.

Authors:  Kevin M Bellew; Joseph G Pigeon; Paul E Stang; William Fleischman; Russell M Gardner; Wilber W Baker
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Oct-Dec       Impact factor: 2.703

5.  Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species.

Authors:  Luciano Cominacini; Anna Pasini; Ulisse Garbin; Stefano Evangelista; Attilio E G Crea; Debora Tagliacozzi; Cristina Nava; Anna Davoli; Vincenzo LoCascio
Journal:  Am J Hypertens       Date:  2002-10       Impact factor: 2.689

6.  Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

Authors: 
Journal:  Lancet       Date:  2001-09-29       Impact factor: 79.321

7.  Duration of antihypertensive drug use and risk of dementia: A prospective cohort study.

Authors:  M D M Haag; A Hofman; P J Koudstaal; M M B Breteler; B H C Stricker
Journal:  Neurology       Date:  2009-02-18       Impact factor: 9.910

8.  Effects of hypertension on attention, memory, and executive function in older adults.

Authors:  Brian K Saxby; Frances Harrington; Ian G McKeith; Keith Wesnes; Gary A Ford
Journal:  Health Psychol       Date:  2003-11       Impact factor: 4.267

9.  Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions.

Authors:  Ilya M Nasrallah; Nicholas M Pajewski; Alexander P Auchus; Gordon Chelune; Alfred K Cheung; Maryjo L Cleveland; Laura H Coker; Michael G Crowe; William C Cushman; Jeffrey A Cutler; Christos Davatzikos; Lisa Desiderio; Jimit Doshi; Guray Erus; Larry J Fine; Sarah A Gaussoin; Darrin Harris; Karen C Johnson; Paul L Kimmel; Manjula Kurella Tamura; Lenore J Launer; Alan J Lerner; Cora E Lewis; Jennifer Martindale-Adams; Claudia S Moy; Linda O Nichols; Suzanne Oparil; Paula K Ogrocki; Mahboob Rahman; Stephen R Rapp; David M Reboussin; Michael V Rocco; Bonnie C Sachs; Kaycee M Sink; Carolyn H Still; Mark A Supiano; Joni K Snyder; Virginia G Wadley; Jennifer Walker; Daniel E Weiner; Paul K Whelton; Valerie M Wilson; Nancy Woolard; Jackson T Wright; Clinton B Wright; Jeff D Williamson; R Nick Bryan
Journal:  JAMA       Date:  2019-08-13       Impact factor: 56.272

Review 10.  Angiotensin-converting enzyme 2 in the brain: properties and future directions.

Authors:  Huijing Xia; Eric Lazartigues
Journal:  J Neurochem       Date:  2008-11-05       Impact factor: 5.372
View more
  6 in total

1.  Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders.

Authors:  Lucy Colbourne; Paul J Harrison
Journal:  Mol Psychiatry       Date:  2022-05-26       Impact factor: 15.992

2.  Visit-to-Visit Blood Pressure Variability and Longitudinal Tau Accumulation in Older Adults.

Authors:  Isabel J Sible; Daniel A Nation
Journal:  Hypertension       Date:  2021-12-30       Impact factor: 10.190

3.  Blood-Brain Barrier Crossing Renin-Angiotensin System Drugs: Considerations for Dementia and Cognitive Decline.

Authors:  Lidia Glodzik; Monica M Santisteban
Journal:  Hypertension       Date:  2021-08-11       Impact factor: 9.897

4.  Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT).

Authors:  Jordana B Cohen; Zachary A Marcum; Chong Zhang; Catherine G Derington; Tom H Greene; Lama Ghazi; Jennifer S Herrick; Jordan B King; Alfred K Cheung; Nick Bryan; Mark A Supiano; Joshua A Sonnen; William S Weintraub; Daniel Scharfstein; Jeff Williamson; Nicholas M Pajewski; Adam P Bress
Journal:  JAMA Netw Open       Date:  2022-07-01

5.  Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson's Disease: A Nationwide Cohort Study.

Authors:  Youngkwon Jo; Seungyeon Kim; Byoung Seok Ye; Euni Lee; Yun Mi Yu
Journal:  Front Pharmacol       Date:  2022-03-03       Impact factor: 5.810

6.  Dysregulation of ACE-1 in Normal Aging and the Early Stages of Alzheimer's Disease.

Authors:  Robert MacLachlan; Patrick Gavin Kehoe; J Scott Miners
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-09-01       Impact factor: 6.591
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.